Actavis To Exit China As Unfriendly Government Not Worth It

Actavis Plc (ACT:US), the second-biggest generic drugmaker by market capitalization, said it will end its presence in China because of the difficult business climate.

Help employers find you! Check out all the jobs and post your resume.